Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18170328 | 0.92 | NAAA (0.36) | NAAA | |
| SCHEMBL6869580 | 0.89 | — | — | |
| SCHEMBL5078471 | 0.88 | CYP2D6 (0.32) | CYP2D6 | |
| SCHEMBL6851006 | 0.82 | CA1 (0.35) | — | |
| SCHEMBL8967007 | 0.82 | ATM (0.30) | — | |
| SCHEMBL17475475 | 0.79 | CYP2D6 (0.30) | CYP2D6 | |
| SCHEMBL6932463 | 0.78 | CHRM2 (0.30) | — | |
| SCHEMBL3661912 | 0.78 | — | — | |
| SCHEMBL10963251 | 0.76 | TSHR (0.36) | CYP2D6 | |
| SCHEMBL6871660 | 0.73 | PRKCA (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4232102-A2 | RESORBABLE COVERING MEMBRANE FOR MEDICAL WOUND AREA TREATMENT | PolyMedics Innovations GmbH (DE) | 2023-08-30 | — | — | EP | disclosed |
| CN-110511328-B | Branched-point-breaking type hyperbranched resin and preparation method and application thereof | 华南理工大学 | 2020-11-24 | — | — | CN | disclosed |
| CN-110540652-B | Degradable hyperbranched resin and preparation method and application thereof | 华南理工大学 | 2020-07-28 | — | — | CN | disclosed |
| CN-110540652-A | degradable hyperbranched resin and preparation method and application thereof | UNIV SOUTH CHINA TECH | 2019-12-06 | — | — | CN | disclosed |
| CN-105288831-A | Hollow tubular biodegradable medication system and preparation method thereof | LIAONING RES INST OF FAMILY PLANNING | 2016-02-03 | — | — | CN | disclosed |
| US-8974814-B2 | Layered drug delivery polymer monofilament fibers | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2015-03-10 | — | — | US | disclosed |
| US-8128954-B2 | Biodegradable drug-polymer delivery system | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2012-03-06 | — | — | US | disclosed |
| EP-2150202-A1 | BIODEGRADABLE PEPTIDE RELEASING POLYMERS | Tyco Healthcare Group LP (US) | 2010-02-10 | — | — | EP | disclosed |
| US-20090155326-A1 | LAYERED DRUG DELIVERY POLYMER MONOFILAMENT FIBERS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2009-06-18 | — | — | US | disclosed |
| WO-2008141326-A1 | BIODEGRADABLE PEPTIDE RELEASING POLYMERS | TYCO HEALTHCARE GROUP LP (US) | 2008-11-20 | — | — | WO | disclosed |
| EP-1871434-A1 | RESORBABLE IMPLANTABLE DEVICES | Suturox Limited (GB) | 2008-01-02 | — | — | EP | disclosed |
| EP-1761283-A2 | BIODEGRADABLE DRUG-POLYMER DELIVERY SYSTEM | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2007-03-14 | — | — | EP | disclosed |
| WO-2006108684-A1 | RESORBABLE IMPLANTABLE DEVICES | SUTUROX LIMITED (GB) | 2006-10-19 | — | — | WO | disclosed |
| WO-2005120578-A9 | BIODEGRADABLE DRUG-POLYMER DELIVERY SYSTEM | CALIFORNIA INST OF TECHN (US) | 2006-04-06 | — | — | WO | disclosed |
| WO-2005120578-A2 | BIODEGRADABLE DRUG-POLYMER DELIVERY SYSTEM | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2005-12-22 | — | — | WO | disclosed |
| US-20050276841-A1 | Biodegradable drug-polymer delivery system | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2005-12-15 | — | — | US | disclosed |
| EP-0527891-B1 | BIODEGRADABLE POLYESTERS FOR SUSTAINED DRUG DELIVERY | RES TRIANGLE INST (US) | 1995-07-26 | — | — | EP | disclosed |
| EP-0527891-A4 | BIODEGRADABLE POLYESTERS FOR SUSTAINED DRUG DELIVERY | — | 1993-05-26 | — | — | EP | disclosed |
| EP-0527891-A1 | BIODEGRADABLE POLYESTERS FOR SUSTAINED DRUG DELIVERY. | RES TRIANGLE INST (US) | 1993-02-24 | — | — | EP | disclosed |
| WO-1991016887-A1 | BIODEGRADABLE POLYESTERS FOR SUSTAINED DRUG DELIVERY | RESEARCH TRIANGLE INSTITUTE (US) | 1991-11-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090155326-A1 | LAYERED DRUG DELIVERY POLYMER MONOFILAMENT FIBERS | MYOF, LPXN, MYOC | NAAA 4768/4885CYP2D6 1074/4885 |
| US-20050276841-A1 | Biodegradable drug-polymer delivery system | GYS1, PYGM, FKBP2 | NAAA 4780/4885CYP2D6 252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.